Cargando…

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Feng, Liang, Yao, Hang-Ping, Sharma, Sharad, Zhou, Yong-Qing, Zhou, Jianwei, Zhang, Ruiwen, Wang, Ming-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912733/
https://www.ncbi.nlm.nih.gov/pubmed/27316712
http://dx.doi.org/10.1186/s13046-016-0364-5
_version_ 1782438313912696832
author Feng, Liang
Yao, Hang-Ping
Sharma, Sharad
Zhou, Yong-Qing
Zhou, Jianwei
Zhang, Ruiwen
Wang, Ming-Hai
author_facet Feng, Liang
Yao, Hang-Ping
Sharma, Sharad
Zhou, Yong-Qing
Zhou, Jianwei
Zhang, Ruiwen
Wang, Ming-Hai
author_sort Feng, Liang
collection PubMed
description
format Online
Article
Text
id pubmed-4912733
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49127332016-06-19 Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer Feng, Liang Yao, Hang-Ping Sharma, Sharad Zhou, Yong-Qing Zhou, Jianwei Zhang, Ruiwen Wang, Ming-Hai J Exp Clin Cancer Res Erratum BioMed Central 2016-06-17 /pmc/articles/PMC4912733/ /pubmed/27316712 http://dx.doi.org/10.1186/s13046-016-0364-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Erratum
Feng, Liang
Yao, Hang-Ping
Sharma, Sharad
Zhou, Yong-Qing
Zhou, Jianwei
Zhang, Ruiwen
Wang, Ming-Hai
Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title_full Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title_fullStr Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title_full_unstemmed Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title_short Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
title_sort erratum to: biological evaluation of antibody-maytansinoid conjugates as a strategy of ron targeted drug delivery for treatment of non-small cell lung cancer
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912733/
https://www.ncbi.nlm.nih.gov/pubmed/27316712
http://dx.doi.org/10.1186/s13046-016-0364-5
work_keys_str_mv AT fengliang erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT yaohangping erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT sharmasharad erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT zhouyongqing erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT zhoujianwei erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT zhangruiwen erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer
AT wangminghai erratumtobiologicalevaluationofantibodymaytansinoidconjugatesasastrategyofrontargeteddrugdeliveryfortreatmentofnonsmallcelllungcancer